Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor

NCT04530305 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT04530305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04530305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Unknown status
Start date
January 7, 2021
Completion date
October 31, 2024
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis